INHIBITION OF 1ST-PASS METABOLISM IN CANCER-CHEMOTHERAPY - INTERACTION OF 6-MERCAPTOPURINE AND ALLOPURINOL

被引：127

作者：

ZIMM, S ^{[1
]}

COLLINS, JM ^{[1
]}

ONEILL, D ^{[1
]}

CHABNER, BA ^{[1
]}

POPLACK, DG ^{[1
]}

机构：

[1] NCI,DIV CANC TREATMENT,CLIN PHARMACOL BRANCH,BETHESDA,MD 20205

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1983年 / 34卷 / 06期

关键词：

D O I：

10.1038/clpt.1983.254

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：810 / 817

页数：8

共 23 条

[1] NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].

BENET, LZ ;

GALEAZZI, RL .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074

[2] CLINICAL EVALUATION OF A NEW ANTIMETABOLITE, 6-MERCAPTOPURINE, IN THE TREATMENT OF LEUKEMIA AND ALLIED DISEASES [J].

BURCHENAL, JH ;

MURPHY, ML ;

ELLISON, RR ;

SYKES, MP ;

TAN, TC ;

LEONE, LA ;

KARNOFSKY, DA ;

CRAVER, LF ;

DARGEON, HW ;

RHOADS, CP .

BLOOD, 1953, 8 (11) :965-999

[3]

COFFEY JJ, 1972, CANCER RES, V32, P1283

[4]

DING TL, 1979, DRUG METAB DISPOS, V7, P373

[5]

ELION GB, 1963, CANCER RES, V23, P1207

[6] POTENTIATION BY INHIBITION OF DRUG DEGRADATION - 6-SUBSTITUTED PURINES AND XANTHINE OXIDASE [J].

ELION, GB ;

RUNDLES, RW ;

NATHAN, H ;

CALLAHAN, S ;

HITCHINGS, GH ;

BIEBER, S .

BIOCHEMICAL PHARMACOLOGY, 1963, 12 (01) :85-&

[7]

ELION GB, 1967, FED PROC, V26, P898

[8] DEPLETION OF ERYTHROCYTE PHOSPHORIBOSYLPYROPHOSPHATE IN MAN - A NEWLY OBSERVED EFFECT OF ALLOPURINOL [J].

FOX, IH ;

WYNGAARD.JB ;

KELLEY, WN .

NEW ENGLAND JOURNAL OF MEDICINE, 1970, 283 (22) :1177-&

[9]

Gibaldi M, 1975, PHARMACOKINETICS, P281

[10]

HAMILTON L, 1954, Ann N Y Acad Sci, V60, P304

← 1 2 3 →